Your browser doesn't support javascript.
loading
Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
Zhong, Yanjun; Zhao, Lishu; Wu, Guobao; Hu, Chunhong; Wu, Chenfang; Xu, Min; Dong, Haiyun; Zhang, Quan; Wang, Guyi; Yu, Bo; Lv, Jianlei; Wu, Chao; Zhang, Siye; Cao, Chenghui; Shu, Long; Pan, Yue; Liu, Xianling; Wu, Fang.
Afiliación
  • Zhong Y; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhao L; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Wu G; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hu C; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Wu C; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Xu M; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Dong H; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhang Q; Department of Critical Care Medicine, the First Hospital of Changsha, Hunan, China.
  • Wang G; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Yu B; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Lv J; Department of Critical Care Medicine, the First Hospital of Changsha, Hunan, China.
  • Wu C; Department of Metabolism & Endocrinology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhang S; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education; National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China.
  • Cao C; Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Shu L; Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Pan Y; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Liu X; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Wu F; Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
J Int Med Res ; 48(12): 300060520979151, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33322988
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Antagonistas de Receptores de Angiotensina / COVID-19 / Hipertensión Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Int Med Res Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / Antagonistas de Receptores de Angiotensina / COVID-19 / Hipertensión Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Int Med Res Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido